Advertisement

Topics

GenScript Starts Construction of Cell Therapy and Antibody Manufacturing Facility

01:44 EDT 17 Apr 2019 | ChinaBio Today

GenScript Biotech, a China biopharma CDMO, has broken ground to build the GenScript-Legend Biotech Commercial Manufacturing Center in Zhenjiang, China. The facility will specialize in manufacturing plasmids and viruses for cell and gene therapies along with monoclonal antibodies. It will be capable of manufacturing both Phase III and commercial levels of production. Legend Biotech, which partnered its early-stage CAR-T therapy with Janssen Pharma in a package that included a $350 million upfront payment, is a subsidiary of GenScript. Legend is building a cell/gene therapy facility in the US as well. More details....

Share this with colleagues:

Original Article: GenScript Starts Construction of Cell Therapy and Antibody Manufacturing Facility

NEXT ARTICLE

More From BioPortfolio on "GenScript Starts Construction of Cell Therapy and Antibody Manufacturing Facility"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...